A 48-year-old woman on atorvastatin 40 mg daily for hypercholesterolaemia reports muscle pain and weakness. Her serum creatine kinase (CK) is 2200 U/L (normal <200 U/L). Which investigation is most appropriate to determine whether statin-induced muscle toxicity is due to myopathy versus rhabdomyolysis?